Gene · 2176
Papers2,586
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,586
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An overview of the osseous palmar sesamoid in Anura, with the particular case of some Rhinella species. | PeerJ | 2023 | 37214098 | PubTator, text mining | PubMed |
| The role of molecular testing in pancreatic cancer. | Ther Adv Gastroenterol | 2023 | 37197396 | PubTator, text mining | PubMed |
| Pathogenic variant profile in DNA damage response genes correlates with metastatic breast cancer progression-free survival in a Mexican-mestizo population. | Front Oncol | 2023 | 37182128 | PubTator, text mining | PubMed |
| miR-145-3p Inhibits MuSCs Proliferation and Mitochondria Mass via Targeting MYBL1 in Jianzhou Big-Eared Goats. | Int J Mol Sci | 2023 | 37176056 | PubTator, text mining | PubMed |
| Molecular Basis for the Selectivity of DHA and EPA in Sudlow's Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations. | Molecules | 2023 | 37175134 | PubTator, text mining | PubMed |
| Consensus clustering methodology to improve molecular stratification of non-small cell lung cancer. | Sci Rep | 2023 | 37173325 | PubTator, text mining | PubMed |
| Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome. | J Gynecol Oncol | 2023 | 37170728 | PubTator, text mining | PubMed |
| Integrated bioinformatic analysis of mitochondrial metabolism-related genes in acute myeloid leukemia. | Front Immunol | 2023 | 37138869 | PubTator, text mining | PubMed |
| Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature. | Thorac Cancer | 2023 | 37095004 | PubTator, text mining | PubMed |
| High tumor mutational burden predicts favorable response to anti-PD-(L)1 therapy in patients with solid tumor: a real-world pan-tumor analysis. | J Immunother Cancer | 2023 | 37094985 | PubTator, text mining | PubMed |
| Emerging bone marrow failure syndromes- new pieces to an unsolved puzzle. | Front Oncol | 2023 | 37091189 | PubTator, text mining | PubMed |
| Fanconi anemia-associated chromosomal radial formation is dependent on POLθ-mediated alternative end joining. | Cell Rep | 2023 | 37086407 | PubTator, text mining | PubMed |
| Health Disparities in Presentation, Treatment, Genomic Testing, and Outcomes of Pancreatic Cancer in Hispanic and Non-Hispanic Patients. | J Racial Ethn Health Disparities | 2023 | 37071331 | PubTator, text mining | PubMed |
| CD86 Is Associated with Immune Infiltration and Immunotherapy Signatures in AML and Promotes Its Progression. | J Oncol | 2023 | 37064861 | PubTator, text mining | PubMed |
| Identifying novel biomarkers associated with bladder cancer treatment outcomes. | Front Oncol | 2023 | 37064102 | PubTator, text mining | PubMed |
| BRCAness, Homologous Recombination Deficiencies, and Synthetic Lethality. | Cancer Res | 2023 | 37057596 | PubTator, text mining | PubMed |
| Altered Mitochondrial Dynamic in Lymphoblasts and Fibroblasts Mutated for FANCA-A Gene: The Central Role of DRP1. | Int J Mol Sci | 2023 | 37047537 | PubTator, text mining | PubMed |
| Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. | Int J Mol Sci | 2023 | 37047231 | PubTator, text mining | PubMed |
| The effect of becoming a Fistula Advocate on the recovery of women with Obstetric Fistula in Sierra Leone: A qualitative study. | PLOS Glob Public Health | 2023 | 37043491 | PubTator, text mining | PubMed |
| Lupus anticoagulant hypoprothrombinemia syndrome: A case report. | Clin Case Rep | 2023 | 37038533 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2176/papers?page=13